53 related articles for article (PubMed ID: 1477333)
1. Intracellular and serum levels of aldolase activity in B chronic lymphocytic leukemia.
Musolino C; Alonci A; Allegra A; Di Cesare E; Orlando A; Grosso P; Buda G; Squadrito G
Int J Hematol; 1992 Dec; 56(3):213-7. PubMed ID: 1477333
[TBL] [Abstract][Full Text] [Related]
2. [Cytochemical detection of lymphocyte 5'-nucleotidase in chronic lymphatic leukemia].
Woessner S; Almarcha J; Marill MR; Florensa L; Besses C; Sans Sabrafén J
Sangre (Barc); 1991 Aug; 36(4):301-4. PubMed ID: 1776109
[TBL] [Abstract][Full Text] [Related]
3. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric analysis of T and Tn epitopes on chronic lymphocytic leukemia cells.
Aller CT; Kucuk O; Springer GF; Gilman-Sachs A
Am J Hematol; 1996 May; 52(1):29-38. PubMed ID: 8638608
[TBL] [Abstract][Full Text] [Related]
5. Immunobiology of chronic lymphocytic leukemia.
Freedman AS
Hematol Oncol Clin North Am; 1990 Apr; 4(2):405-29. PubMed ID: 2182599
[TBL] [Abstract][Full Text] [Related]
6. Glutathione-S-transferase activity and multidrug resistance phenotype in chronic lymphocytic leukemia: do they have any clinical relevance?
Di Simone D; Testi R; Caracciolo F; Capochiani E; Ambrogi F; Grassi B; Petrini M
Haematologica; 1995; 80(2):103-7. PubMed ID: 7543067
[TBL] [Abstract][Full Text] [Related]
7. A multicenter retrospective clinical study of CD5/CD10-negative chronic B cell leukemias.
Goldaniga M; Ferrario A; Cortelazzo S; Guffanti A; Pavone E; Ambrosetti A; Marcheselli L; Rossi F; Luminari S; Rossi A; Cro L; Federico M; Lambertenghi Deliliers G; Baldini L
Am J Hematol; 2008 May; 83(5):349-54. PubMed ID: 18186522
[TBL] [Abstract][Full Text] [Related]
8. The clinical and laboratory approach to the CD5/CD10 negative B-cell chronic lymphoproliferative leukemias.
Hanson CA; Morice WG
Am J Hematol; 2008 May; 83(5):347-8. PubMed ID: 18383327
[No Abstract] [Full Text] [Related]
9. B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules.
Trentin L; Zambello R; Sancetta R; Facco M; Cerutti A; Perin A; Siviero M; Basso U; Bortolin M; Adami F; Agostini C; Semenzato G
Cancer Res; 1997 Nov; 57(21):4940-7. PubMed ID: 9354461
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneous intracellular expression of B-cell receptor components in B-cell chronic lymphocytic leukaemia (B-CLL) cells and effects of CD79b gene transfer on surface immunoglobulin levels in a B-CLL-derived cell line.
Minuzzo S; Indraccolo S; Tosello V; Piovan E; Cabrelle A; Trentin L; Semenzato G; Amadori A
Br J Haematol; 2005 Sep; 130(6):878-89. PubMed ID: 16156858
[TBL] [Abstract][Full Text] [Related]
11. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.
Bojarska-Junak A; Rolinski J; Wasik-Szczepaneko E; Kaluzny Z; Dmoszynska A
Haematologica; 2002 May; 87(5):490-9. PubMed ID: 12010662
[TBL] [Abstract][Full Text] [Related]
12. Immunoregulatory T cells in B cell chronic lymphocytic leukaemia: evidence of a unique phenotype a flow cytometric study.
Mackenzie RH; Sewell HF; Dawson AA; Ratcliffe MA; Bennett NB; King DJ
Dis Markers; 1990; 8(3):137-43. PubMed ID: 1703059
[TBL] [Abstract][Full Text] [Related]
13. Chronic lymphocytic leukemia coexisting with chronic myelomonocytic leukemia.
Ferrara F; Del Vecchio L; Antonolfi I; Mele G; Rametta V; Cimino R
Haematologica; 1992; 77(2):171-3. PubMed ID: 1398303
[TBL] [Abstract][Full Text] [Related]
14. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
Kusenda J; Babusíková O
Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
[TBL] [Abstract][Full Text] [Related]
15. Immunophenotypic characteristics of T-acute lymphoblastic leukemia cells in relation to DPP IV enzyme expression.
Klobusická M; Babusíková O
Neoplasma; 1998; 45(4):237-42. PubMed ID: 9890667
[TBL] [Abstract][Full Text] [Related]
16. Ribonucleotide content of mononuclear cells from normal subjects and patients with chronic lymphocytic leukemia: increased nicotinamide adenine dinucleotide concentration in chronic lymphocytic leukemia lymphocytes.
Liebes LF; Krigel RL; Conklyn M; Nevrla DR; Silber R
Cancer Res; 1983 Nov; 43(11):5608-17. PubMed ID: 6604577
[TBL] [Abstract][Full Text] [Related]
17. Expression of inhibitory receptor ILT3 on neoplastic B cells is associated with lymphoid tissue involvement in chronic lymphocytic leukemia.
Colovai AI; Tsao L; Wang S; Lin H; Wang C; Seki T; Fisher JG; Menes M; Bhagat G; Alobeid B; Suciu-Foca N
Cytometry B Clin Cytom; 2007 Sep; 72(5):354-62. PubMed ID: 17266150
[TBL] [Abstract][Full Text] [Related]
18. Production of intracellular IL-2, TNF-alpha, and IFN-gamma by T cells in B-CLL.
Gallego A; Vargas JA; Castejón R; Citores MJ; Romero Y; Millán I; Durántez A
Cytometry B Clin Cytom; 2003 Nov; 56(1):23-9. PubMed ID: 14582134
[TBL] [Abstract][Full Text] [Related]
19. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
Hojjat Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Shamsian Khoramabadi A; Rabbani H; Shokri F
Iran J Immunol; 2008 Mar; 5(1):25-35. PubMed ID: 18319522
[TBL] [Abstract][Full Text] [Related]
20. Differences in constitutive and activation-induced expression of CD69 and CD95 between normal and chronic lymphocytic leukemia B cells.
De Fanis U; Romano C; Dalla Mora L; Sellitto A; Guastafierro S; Tirelli A; Bresciano E; Giunta R; Lucivero G
Oncol Rep; 2003; 10(3):653-8. PubMed ID: 12684639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
